News Image

NASDAQ:NBIX stands out as a growth opportunity that won't break the bank.

By Mill Chart

Last update: Jan 15, 2025

Consider NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) as an affordable growth stock, identified by our stock screening tool. NASDAQ:NBIX is showcasing impressive growth figures and is well-positioned in terms of profitability, solvency, and liquidity. Moreover, it seems to be priced reasonably. Let's dive deeper into the analysis.


Affordable growth stocks image

Growth Examination for NASDAQ:NBIX

Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NASDAQ:NBIX boasts a 9 out of 10:

  • The Earnings Per Share has grown by an impressive 100.54% over the past year.
  • Measured over the past years, NBIX shows a very strong growth in Earnings Per Share. The EPS has been growing by 70.09% on average per year.
  • Looking at the last year, NBIX shows a very strong growth in Revenue. The Revenue has grown by 25.72%.
  • NBIX shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 33.13% yearly.
  • Based on estimates for the next years, NBIX will show a very strong growth in Earnings Per Share. The EPS will grow by 47.17% on average per year.
  • NBIX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.34% yearly.

What does the Valuation looks like for NASDAQ:NBIX

ChartMill employs its own Valuation Rating system for all stocks. This score, ranging from 0 to 10, is determined by evaluating different valuation factors, including price to earnings and free cash flow, both in absolute terms and relative to the market and industry. NASDAQ:NBIX has earned a 7 for valuation:

  • 94.34% of the companies in the same industry are more expensive than NBIX, based on the Price/Earnings ratio.
  • NBIX's Price/Forward Earnings ratio is rather cheap when compared to the industry. NBIX is cheaper than 93.81% of the companies in the same industry.
  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NBIX indicates a rather cheap valuation: NBIX is cheaper than 95.58% of the companies listed in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of NBIX indicates a rather cheap valuation: NBIX is cheaper than 95.04% of the companies listed in the same industry.
  • NBIX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • NBIX has an outstanding profitability rating, which may justify a higher PE ratio.
  • NBIX's earnings are expected to grow with 53.84% in the coming years. This may justify a more expensive valuation.

A Closer Look at Health for NASDAQ:NBIX

ChartMill assigns a Health Rating to every stock. This score ranges from 0 to 10 and evaluates the different health aspects like liquidity and solvency, both absolutely, but also relative to the industry peers. NASDAQ:NBIX scores a 8 out of 10:

  • NBIX has an Altman-Z score of 12.09. This indicates that NBIX is financially healthy and has little risk of bankruptcy at the moment.
  • NBIX has a better Altman-Z score (12.09) than 88.85% of its industry peers.
  • NBIX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
  • A Current Ratio of 4.37 indicates that NBIX has no problem at all paying its short term obligations.
  • A Quick Ratio of 4.26 indicates that NBIX has no problem at all paying its short term obligations.

Profitability Analysis for NASDAQ:NBIX

ChartMill assigns a Profitability Rating to every stock. This score ranges from 0 to 10 and evaluates the different profitability ratios and margins, both absolutely, but also relative to the industry peers. NASDAQ:NBIX scores a 9 out of 10:

  • With an excellent Return On Assets value of 10.92%, NBIX belongs to the best of the industry, outperforming 96.46% of the companies in the same industry.
  • With an excellent Return On Equity value of 14.19%, NBIX belongs to the best of the industry, outperforming 96.28% of the companies in the same industry.
  • NBIX has a Return On Invested Capital of 13.96%. This is amongst the best in the industry. NBIX outperforms 96.99% of its industry peers.
  • The last Return On Invested Capital (13.96%) for NBIX is above the 3 year average (9.89%), which is a sign of increasing profitability.
  • The Profit Margin of NBIX (17.21%) is better than 96.46% of its industry peers.
  • NBIX's Profit Margin has improved in the last couple of years.
  • NBIX's Operating Margin of 26.23% is amongst the best of the industry. NBIX outperforms 97.17% of its industry peers.
  • NBIX's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 98.52%, NBIX belongs to the top of the industry, outperforming 97.70% of the companies in the same industry.

Every day, new Affordable Growth stocks can be found on ChartMill in our Affordable Growth screener.

For an up to date full fundamental analysis you can check the fundamental report of NBIX

Keep in mind

Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.

Back

NEUROCRINE BIOSCIENCES INC

NASDAQ:NBIX (1/14/2025, 8:00:01 PM)

After market: 139.51 0 (0%)

139.51

-3.52 (-2.46%)

Follow us for more